A carregar...
Emerging drugs for respiratory syncytial virus infection
Although respiratory syncytial virus (RSV) was discovered > 40 years ago, treatment remains largely supportive. There are no safe and effective vaccines or specific treatments other than prophylaxis with passive antibody therapy (palivizumab). However, there are good reasons to think that the sce...
Na minha lista:
Main Authors: | , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2009
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2705842/ https://ncbi.nlm.nih.gov/pubmed/19453286 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14728210902946399 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|